Options Trading News

April 16, 2013  Tue 7:32 AM CT

Europe, Emerging Markets Strong

Coca-Cola earned $0.46 a share in the first quarter on revenue of $11.04 billion. Analysts had only expected $0.45 and $10.94 billion, respectively. Management cited strong demand in Europe and emerging markets. KO advances almost 4 percent before the bell on my tradeMONSTER platform.

FDA Request Sends Sarepta Lower

The Food and Drug Administration asked Sarepta Therapeutics for additional information on its eteplirsen drug for the treatment of Duchenne muscular dystrophy. The summaries requested are to come from the existing data and won't require new research, but SRPT is still down by almost 7 percent in early trading.

Weak Admissions, Outlook Hurt HCA

Hospital operator HCA Holding warned that first-quarter revenue was only $8.44 million, less than the $8.63 billion number expected by analysts. Management cited weak admissions and outpatient levels. HCA drops 3 percent.
Share this article with your friends



The fastest money in the market
View full report »

Premium Services

Education & Strategy

It's Not Quite as Simple as 2+2=4

One of the things that I am constantly reminding many individual investors of is that trading is not a science. It is an art form that is based in mathematics.

View more education articles »